Aligned Genetics Inc Cash Flow Reinvestment Rate
Aligned Genetics Inc cash flow reinvestment rate. Aligned Genetics Inc (238120) has a Cash Flow Reinvestment Rate of 0.39x as of June 2025, reinvesting ₩265.20 Million (capex ₩165.20 Million plus investments ₩100.00 Million) from operating cash flow of ₩677.20 Million. Explore cash flow to debt ratio of Aligned Genetics Inc to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Aligned Genetics Inc (2019–2024)
Cash flow reinvestment rate of Aligned Genetics Inc from 2019 to 2024. Historical reinvestment intensity for Aligned Genetics Inc across 6 annual periods. Explore 238120 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Aligned Genetics Inc Cash Flow Reinvestment Rate by Year (2019–2024)
Aligned Genetics Inc cash flow reinvestment rate by year from 2019 to 2024. Year-by-year capital reinvestment analysis for Aligned Genetics Inc. For the full cash flow conversion analysis, see 238120 cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.57x | ₩7.89 Billion | ₩3.07 Billion | ₩340.06 Million | ▲ +237.6% |
| 2023 | 0.76x | ₩2.17 Billion | ₩2.85 Billion | ₩880.42 Million | ▼ -71.8% |
| 2022 | 2.70x | ₩6.00 Billion | ₩2.22 Billion | ₩2.00 Billion | ▼ -89.7% |
| 2021 | 26.15x | ₩3.56 Billion | ₩135.97 Million | ₩3.31 Billion | ▲ +17.1% |
| 2020 | 22.33x | ₩796.38 Million | ₩35.67 Million | ₩96.43 Million | ▲ +655.8% |
| 2019 | 2.95x | ₩1.95 Billion | ₩659.29 Million | ₩261.62 Million | — |